# Inova Schar Cancer Institute – FDA Inspection, Sep 26, 2017

Source: https://www.keypedia.com/records/fda_inspections/inova-schar-cancer-institute/dffa3539-7927-481d-a0fc-3a00a83b4962
Source feed: FDA_Inspections

> FDA inspection 1026568 of Inova Schar Cancer Institute, September 26, 2017. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 606. Form 483 issued. 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1026568
- Company Name: Inova Schar Cancer Institute
- Inspection Date: 2017-09-26
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 1

## Related Documents

- FDA Inspection 1266988 - 2025-04-09
- FDA Inspection 1167056 - 2022-03-31
- FDA Inspection 1117080 - 2020-01-15
- [FDA Inspection 930127 - 2015-06-16](https://www.keypedia.com/records/fda_inspections/inova-schar-cancer-institute/4df8de84-4460-4b7c-afb1-ee7ab9d3bb6e)
- [FDA Inspection 849408 - 2013-09-25](https://www.keypedia.com/records/fda_inspections/inova-schar-cancer-institute/4f1bb590-57a7-4549-bd50-b8336c4bc0c6)

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/la-tasha-m-gunter/db9cd9cf-db0a-4c31-9f7c-24760750f34d)

Company: https://www.keypedia.com/companies/inova-schar-cancer-institute/c71f9b12-77e8-4263-9c80-c4c60ddbe6cd

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d